Renivace and liver disorder Patient Reports February 13, 2012

Renivace Side Effects Report #5162019-5
Renivace side effect was reported by a Physician from JAPAN on Nov 07, 2006. Male patient, 73 years of age, weighting 163.1 lb, was diagnosed with myocardial infarction, gastric ulcer haemorrhage, sepsis  and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, chills, cholelithiasis, gamma-glutamyltransferase increased, hepatic infiltration eosinophilic, liver disorder, pyrexia. Renivace dosage: 2.5 MG BID PO. During the same period patient was treated with GASTER, GASTER D, PAZUCROSS, PANALDINE, ARTIST, ASPIRIN, SIGMART. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5143257-4
Renivace side effect was reported by a Physician from JAPAN on Oct 13, 2006. Male patient, 73 years of age, weighting 163.1 lb, was diagnosed with hypertension, gastric ulcer, gastric ulcer haemorrhage, sepsis , angina pectoris, myocardial infarction and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gastric ulcer haemorrhage, hepatic infiltration eosinophilic, liver disorder. Renivace dosage: 2.5 MG BID PO. During the same period patient was treated with FAMOTIDINE, GASTER D, PAZUCROSS, PANALDINE, ARTIST, ASPIRIN, SIGMART. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5584657-8
Renivace side effect was reported by a Physician from JAPAN on Dec 18, 2007. Male patient, 71 years of age, was diagnosed with hypertension, prophylaxis and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, international normalised ratio increased, liver disorder, prothrombin time prolonged. Renivace dosage: (5 MG QD ORAL). During the same period patient was treated with BAYASPIRIN, WARFARIN, DIGOXIN, MUCOSTA, MAGNESIUM OXIDE, GLYSENNID. Patient recovered.

Renivace Side Effects Report #5085260-9
Renivace side effect was reported by a Physician from ALBANIA on July 31, 2006. Male patient, 70 years of age, weighting 149.9 lb, was diagnosed with hypertension, angina pectoris, coronary arterial stent insertion, hyperlipidaemia, hypertonia and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, liver disorder, lymphocyte stimulation test, lymphocyte stimulation test positive. Renivace dosage: 5 MG Q DAY PO. During the same period patient was treated with PANALDINE, LIVALO, SIGMART, CALBLOCK, ARTIST. Patient was hospitalized. Patient recovered.


Renivace Side Effects Report #5102516-1
Renivace side effect was reported by a Physician from JAPAN on Aug 23, 2006. Male patient, 70 years of age, weighting 149.9 lb, was diagnosed with hypertension, angina pectoris, coronary arterial stent insertion, hyperlipidaemia, hypertonia and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, liver disorder, lymphocyte stimulation test positive. Renivace dosage: 5 MG Q DAY PO. During the same period patient was treated with PANALDINE, LIVALO, SIGMART, CALBLOCK, ARTIST. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5053306-X
Renivace side effect was reported by a Physician from JAPAN on June 26, 2006. Male patient was diagnosed with cardiac failure and was treated with Renivace. After drug was administered, patient experienced the following side effects: liver disorder, lymphocyte stimulation test positive. Renivace dosage: 5 MG QD PO. During the same period patient was treated with ASPIRIN, PANALDINE, LIVALO, SIGMART. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5393082-4
Renivace side effect was reported by a Physician from JAPAN on July 03, 2007. Female patient was treated with Renivace. After drug was administered, patient experienced the following side effects: cough, liver disorder, nephrotic syndrome. Renivace dosage: (10 MG QD ORAL), (5 MG QD ORAL). Patient was hospitalized. Patient recovered.